drugset / Trial / NCT03383198

Pectoralis (II) Block With Liposomal Bupivacaine vs Bupivacaine for Breast Surgery

NCT03383198 ↗

Phase 4 Terminated 5 enrolled Prisma Health-Upstate
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a randomized controlled pilot study evaluating length of pain control with either liposomal bupivacaine or with bupivacaine plus decadron after PEC II injection in patients having bilateral mastectomies with immediate reconstruction.

Timeline

Start
2017-12-01
Primary completion
2019-08-30
Completion
2019-08-30

Outcome

Outcome not reported

Stopped: “Early termination due to manufacturer discontinued supplying the product for the study.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified — Other

Indications